WU
Usynova Biopharmaceuticals develops small molecule targeted therapies, recombinant proteins, and monoclonal antibodies specifically for cancer and autoimmune diseases. The company focuses on addressing unmet clinical needs by creating novel drugs with proprietary intellectual property to enhance treatment efficacy and improve patient outcomes.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Usynova Biopharmaceuticals develops small molecule targeted therapies, recombinant proteins, and monoclonal antibodies specifically for cancer and autoimmune diseases. The company focuses on addressing unmet clinical needs by creating novel drugs with proprietary intellectual property to enhance treatment efficacy and improve patient outcomes.